VALUATION

How behavioral health practices are valued

Behavioral health practices are valued on adjusted EBITDA, with the multiple driven by clinician retention, payer rates, service mix, and how much capacity exists to grow without new capital. Prescriber led practices and ABA providers with strong utilization generally price above therapy only groups of the same size.

8.2x

Broad middle-market average

155

2024 Behavioral Deals

$119.7M

LifeStance Adj EBITDA

The drivers buyers weigh

Within behavioral health the same questions come up in nearly every diligence process.

Revenue per clinician
The clearest single measure of operating discipline in outpatient behavioral health.
Payer mix and rates
In network commercial contracts, Medicaid participation, and rate trend by payer.
Clinician stability
Turnover, employment model, and how dependent revenue is on any one provider.
Service mix
Psychiatry, therapy, ABA, intensive outpatient, and MAT each carry their own multiple range.
Compliance posture
Documentation quality, coding accuracy, licensure status, and accreditation.

Why the ranges are wide

Behavioral health multiples span a wide band because the segment spans very different businesses, from a two clinician therapy group to an accredited multi state treatment platform. Scale compresses risk, so larger platforms trade well above small practices, and the step up between them is one reason owners take rollover equity rather than selling everything at a small company multiple.

Structure often matters more than multiple

Between two offers at similar prices, the differences that change your life are cash at close, earnout size and how achievable its targets are, rollover percentage and its terms, your required commitment period, and what happens to your clinicians. We push these into the first conversation so you are comparing real outcomes rather than headline numbers.

The Dangers of Comparing to Public Companies

Owners should not use public-company operating results as a valuation proxy. It is a common mistake to look at the trading multiples of public companies like LifeStance and assume their practice is worth a similar amount. For FY2024, LifeStance reported $1.251 billion in revenue and $119.7 million in adjusted EBITDA. Public companies have much higher levels of liquidity, diversification, and access to debt markets. A private practice owner should focus on their own specific margins and compliance profile.

Valuation is also highly sensitive to clinician retention. In a field where the demand for therapists far exceeds the supply, your ability to keep staff is a direct proxy for the health of your business. If you have a high turnover rate, a buyer will likely assume they will need to spend significant capital on recruitment, which will lead them to offer a lower multiple. Professional financial advice is recommended to accurately assess these risks.

Illustrative example: Rollover Equity Upside

A seller accepts a $10M valuation for their clinic: $8M in cash and $2M in 'rollover' equity in the buyer's company (representing a 20% stake). Three years later, the buyer sells the combined platform for a higher multiple. If the total platform value has doubled, the seller's $2M rollover could potentially be worth $4M. However, if the platform fails, that $2M could be worth zero.

The Working Capital Peg

One of the most misunderstood parts of valuation is the working capital 'peg.' During a sale, the buyer and seller agree on a target level of working capital that must stay in the business at closing. This typically includes accounts receivable, prepaid expenses, accounts payable, and accrued liabilities. If the actual working capital at closing is lower than the peg, the purchase price is reduced dollar-for-dollar.

In behavioral health, this is particularly tricky because of the time it takes to collect from insurance companies. If your billing is lagging, your working capital might look artificially low. Conversely, if you have a lot of old, uncollectible debt on your books, the buyer will exclude it from the calculation. Ensuring your billing cycle is clean and efficient in the months before a sale is one of the best ways to protect your valuation. This guide is for informational purposes only.

Sources and methodology

Public transactions provide market context, not a valuation quote for a private practice. Illustrative examples use hypothetical assumptions and are not predictions. This guide is educational and is not legal, tax, accounting, or investment advice.

  1. 1. Middle Market M&A Update Q4 2024 (MNP / GF Data). Provides the 8.2x average EV/EBITDA figure for 2024 healthcare services deals.
  2. 2. Mertz Taggart 2024 M&A Reports (Mertz Taggart). Supports the total transaction count of 155 for behavioral health in 2024.

Reviewed September 2026

Questions owners ask

Straight answers, before you commit to anything.

Do I need audited financials?+

No. Clean accrual based statements, a payer level revenue report, and a provider level productivity report are usually enough to start. The buyer funds a quality of earnings review later.

How much does a waitlist add to value?+

It rarely adds directly to the multiple, but it makes the practice far more attractive to buyers with recruiting capacity and often improves the terms you are offered.

Should I get a formal appraisal first?+

Appraisals answer a different question than the market does. Seeing what several real acquirers say about your practice costs you nothing and is usually more informative.

Confidential inquiry

Tell us about your practice.

Everything you send stays between us. We never list or shop a practice, and nothing goes to a buyer without your explicit approval. There is no cost to you at any stage.